Summary
This study shows that two therapeutic agents, anti-CD4 mAb and vinblastine, capable of causing T-cellmediated regression of an established L5178Y lymphoma in 3-month-old mice, are incapable of causing regression of this tumor in 20- to 22-month-old mice. It is known that both agents are immunoaugmentative because of their ability to destroy tumor-induced CD4+ suppressor T cells preferentially. Therefore, the results indicate, that aged mice, unlike young mice, are not capable of generating therapeutic numbers of CD8+ effector T cells in the absence of suppressor cells.
This is a preview of subscription content, log in via an institution to check access.
References
Awwad M, North RJ (1988) Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J Exp Med 168: 2193–2206
Dunn PL, North RJ (1991) Selective radiation resistance of immunologically induced T cells as the basis for irradiation-induced T-cellmediated regression of an immunogenic tumor. J Leukocyte Biol 49: 388–396
Flood PM, Urban JL, Kripke ML, Schrieber H (1981) Loss of tumorspecific and idiotype-specific immunity with age. J Exp Med 154: 275–290
Fitzgerald PA, Bennett M (1983) Aging of natural and acquired immunity of mice: II. Decreased T cell response to syngeneic tumor cells and parenteral-strain spleen cells. Cancer Invest 1: 139
Johnson TR, North RJ (1987) Frequency analysis of augmented CTL production associated withCorynebacterium parvum-induced tumor regression. Immunology 60: 361–366
Mackinodan T, Kay MMB (1980) Age influence on the immune system. Adv Immunol 29: 287–294
North RJ, Awwad M (1990) Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma. Immunology 71: 90–95
North RJ, Awwad M, Dunn PL (1989) The immune response to tumors. Transplant Proc 21: 575–577
Smith GS, Walford RL, Mickey MR (1973) Life span and incidence of cancer and other diseases in selected long-lived mice and their F1 hybrids. J Natl Cancer Inst 50: 1195–1213
Thoman ML, Weigle WO (1989) The cellular and subcellular basis of immunosenescence. Adv Immunol 46: 221–261
Urban JL, Schrieber H (1984) Rescue of tumor-specific immune response of aged mice in vitro. J Immunol 133: 527–534
Wade AW, Szewczuk MR (1984) Aging, idiotype repertoire shifts, and compartmentalization of the mucosal-associated lymphoid system. Adv Immunol 36: 143
Author information
Authors and Affiliations
Additional information
The work was supported by grants CA-16 642 and CA-27 794 from the National Cancer Institute and a grant from the Jennie R. and Oliver S. Donaldson Trust
Rights and permissions
About this article
Cite this article
Dunn, P.L., North, R.J. Effect of advanced aging on ability of mice to cause regression of an immunogenic lymphoma in response to immunotherapy based on depletion of suppressor T cells. Cancer Immunol Immunother 33, 421–423 (1991). https://doi.org/10.1007/BF01741605
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741605